Key features and details
- Assay type: Cell-based (quantitative)
- Detection method: Fluorescent
- Platform: Microplate reader
- Assay time: 1 hr 30 min
- Sample type: Adherent cells, Suspension cells
Product nameGlycolysis Assay [Extracellular acidification]
Sample typeAdherent cells, Suspension cells
Assay typeCell-based (quantitative)
Assay time1h 30m
Glycolysis Assay [Extracellular Acidification] (ab197244) is an easy mix-and-measure, 96 well fluorescence plate reader-based approach for the analysis of extracellular acidification (ECA/ECAR). As lactate production is the main contributor to this acidification, ab197244 is a convenient and informative measure of cellular glycolytic flux. Such measurements offer an important insight into the central role played by altered glycolytic activity in a wide array of physiological and pathophysiological processes, including cellular adaptation to hypoxia and ischemia, and the development and progression of tumorigenesis.
The performance of Glycolysis Assay facilitates sensitive robust microtiter-plate based measurements, thereby overcoming many of the problems associated with the more cumbersome potentiometric pH approach. Rates of extracellular acidification are calculated from changes in fluorescence signal over time and, as the measurement is non-destructive and fully reversible (pH-sensitive reagent is not consumed), measurement of time-courses and multiple drug treatments are possible.
Learn more about the full range of assays to measure glycolysis, oxygen consumption, fatty acid oxidation and metabolic flux in live cells.
Or review the full metabolism assay guide for other assays for metabolites, metabolic enzymes, mitochondrial function, and oxidative stress.
Storage instructionsStore at +4°C. Please refer to protocols.
Components 96 tests 4 x 96 tests Glycolysis Assay Reagent (lyophilized) 1 vial 4 vials Respiration Buffer 1 tablet 4 tablets
- Pathways and Processes
- Metabolic signaling pathways
- Energy transfer pathways
- Integration of energy
Cellular Energy Flux for HepG2 cells (seeded at 65,000 per well), treated with a combination of drug compounds modulating the ETC (Antimycin A [1 µM] and FCCP [2.5 µM]), shown as a percentage relative to untreated control cells. Comparative measurements were taken with Extracellular Oxygen Consumption Assay (ab197243) (white column) and Glycolysis Assay [Extracellular acidification] (ab197244) (black column) show the shift between mitochondrial respiration and glycolysis and the cellular control of energy (ATP; measured 1h post-treatment using Luminescent ATP Detection Assay kit (ab113849) (striped column)).
Typical Lifetime profile of Glycolysis Assay for adherent cells, treated with typical control compounds, including Oxamic acid recommended as a negative control. The effect of Glucose Oxidase as a positive signal control is illustrated schematically.
Excitation and Emission spectra of Glycolysis Assay. Left panel shows normalized excitation (Ex 340 – 410nm; Peak 360-380nm). Right panel shows emission maxima (Em 590, 615 and 690nm) fold increase between pH6.0 and pH7.5.
ab197244 has been referenced in 13 publications.
- Martí JM et al. Selective modulation by PARP-1 of HIF-1a-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions. Redox Biol 41:101885 (2021). PubMed: 33581682
- Baranska E et al. Interactions of a Water-Soluble Glycofullerene with Glucose Transporter 1. Analysis of the Cellular Effects on a Pancreatic Tumor Model. Nanomaterials (Basel) 11:N/A (2021). PubMed: 33670509
- McKelvey KJ et al. Glycolysis and Fatty Acid Oxidation Inhibition Improves Survival in Glioblastoma. Front Oncol 11:633210 (2021). PubMed: 33854970
- Zhao Z et al. miR-16-5p/PDK4-Mediated Metabolic Reprogramming Is Involved in Chemoresistance of Cervical Cancer. Mol Ther Oncolytics 17:509-517 (2020). PubMed: 32577500
- Zhao P et al. Aminooxyacetic acid attenuates post-infarct cardiac dysfunction by balancing macrophage polarization through modulating macrophage metabolism in mice. J Cell Mol Med 24:2593-2609 (2020). PubMed: 31930778